Erasca to Present at the 8th Annual Evercore Healthcare Conference

Erasca (Nasdaq: ERAS) will present at the 8th Annual Evercore Healthcare Conference in Coral Gables, FL.

Rhea-AI Summary

Erasca (Nasdaq: ERAS) will present at the 8th Annual Evercore Healthcare Conference in Coral Gables, FL.

Management will take part in a fireside chat on Wednesday, December 3, 2025 at 10:25 AM ET, hold one-on-one investor meetings, and provide a live audio webcast at Erasca.com/events. An archived replay will be available for 30 days after the webcast.

Argus Nov 25 session

+6.23% close to close Open Argus

Details

News Market Reaction – ERAS

On Nov 25, the day this news came out, ERAS closed 6.23% above the previous close.

Data tracked by StockTitan Argus for the Nov 25 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the 8^th Annual Evercore Healthcare Conference being held at the Loews Coral Gables Hotel in Coral Gables, FL. Management will participate in a fireside chat on Wednesday, December 3, 2025, at 10:25 am Eastern Time and will also participate in one-on-one investor meetings.

A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Erasca (ERAS) present at the Evercore Healthcare Conference?

Erasca will present on Wednesday, December 3, 2025 at 10:25 AM ET.

How can investors watch Erasca's (ERAS) presentation at the December 3, 2025 Evercore conference?

A live audio webcast will stream at Erasca.com/events.

Will Erasca (ERAS) offer a replay of its Evercore Healthcare Conference presentation?

Yes. An archived replay will be available for 30 days after the webcast at Erasca.com/events.

Where is the 8th Annual Evercore Healthcare Conference taking place for Erasca's (ERAS) presentation?

The conference is at the Loews Coral Gables Hotel, Coral Gables, FL.

Will Erasca (ERAS) meet with investors at the Evercore Healthcare Conference?

Yes. Management will participate in one-on-one investor meetings in addition to the fireside chat.